China removes import duties on 28 medicines; move likely to boost Indian pharma industry

New Delhi: China Thursday said it has removed import duties on as many as 28 medicines, including all cancer drugs, from 1 May, a move which would help India to export these pharmaceuticals to the neighbouring country. [caption id=“attachment_4455871” align=“alignleft” width=“380”] Representational image. Reuters[/caption] “China has exempted import tariffs (duties) for 28 drugs, including all cancer drugs, from 1 May. Good news for India’s pharmaceutical industry and medicine export to China. I believe this will help reduce trade imbalance between China and India in the future,” Chinese Ambassador to India Luo Zhaohui said in a tweet. The development assumes significance as India has time and again asked for greater market access for its goods and services, including IT, pharmaceuticals and agriculture, in the Chinese market to reduce the widening trade deficit. In the meeting of India China Joint Group on Economic Relations, Trade, Science and Technology here, the issue of trade imbalance was discussed in detail. China on its part promised to address the trade gap issue. The trade deficit with China stood at $36.73 billion during April-October 2017-18. It was $51 billion in 2016-17. He also said that China would further improve the business environment by halving the time required to open a business. “China’s door to the outside world will open wider. Indian businesses are welcome,” he added. India too has sought investments from China. The neighbouring country has agreed to set up industry park in India to increase investments and bridge trade deficit.